Article
Graft-versus-host disease
27 Jan 2014
Abstract excerpt
PURPOSE OF REVIEW: Although allogeneic hematopoietic stem cell transplantation (allo-SCT) is potentially curative for a number of hematologic malignancies, its use is limited by the development of acute and chronic graft-versus-host disease (GVHD). This potentially fatal complication occurs in approximately 50% of allo-SCT recipients. RECENT FINDINGS: The pathogenesis of acute and chronic GVHD remains poorly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
